KZR
Kezar Life Sciences Inc.
$6.21
-$0.02(-0.32%)
54
Overall
60
Value
75
Tech
28
Quality
Market Cap
$45.77M
Volume
41.18K
52W Range
$3.53 - $7.65
Target Price
$6.00
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | -- | -- | -- | -- | -- | $7.0M | -- | ||
| Total Revenue | -- | -- | -- | -- | -- | $7.0M | -- | ||
| GROSS PROFIT | |||||||||
| Gross Profit | -- | -- | -- | -- | -- | $7.0M | -- | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $24.7M | $37.3M | $43.0M | $54.7M | $71.2M | $118.4M | $90.6M | ||
| Research & Development | $18.1M | $27.4M | $31.0M | $38.9M | $51.0M | $85.7M | $65.7M | ||
| Research Expense | $18.1M | $27.4M | $31.0M | $38.9M | $51.0M | $85.7M | $65.7M | ||
| Selling, General & Administrative | $6.6M | $10.0M | $12.0M | $15.7M | $20.2M | $26.5M | $23.4M | ||
| General & Administrative Expenses | $6.6M | $10.0M | $12.0M | $15.7M | $20.2M | $26.5M | $23.4M | ||
| Salaries & Wages | $-2.0M | -- | -- | -- | -- | $18.1M | $13.0M | ||
| Depreciation & Amortization | $-700.0K | $900.0K | $900.0K | $900.0K | $1.0M | $1.1M | $1.0M | ||
| Depreciation & Amortization | $-700.0K | $900.0K | $900.0K | $900.0K | $1.0M | $1.1M | $1.0M | ||
| Other Operating Expenses | $-24.7M | $37.3M | $-487.0K | $-775.0K | $-1.1M | $-1.8M | $-933.0K | ||
| OPERATING INCOME | |||||||||
| Operating income | $-24.7M | $-37.3M | $-43.0M | $-54.7M | $-71.2M | $-111.4M | $-90.6M | ||
| EBITDA | $-23.0M | $-34.8M | $-40.2M | $-53.0M | $-66.0M | $-100.6M | $-82.4M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $159.0K | $1.2M | $1.6M | -- | ||
| Intinc | $1.6M | $2.3M | $1.2M | $188.0K | $4.1M | $11.1M | $8.5M | ||
| Net Non-Operating Interest Income/Expense | $1.6M | $2.3M | $1.2M | $29.0K | $2.9M | $11.1M | $8.5M | ||
| Other Income/Expense | -- | -- | -- | -- | -- | $2.7M | $1.5M | ||
| SPECIAL ITEMS | |||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | $6.2M | $1.5M | ||
| Special Income Charges | -- | -- | -- | -- | -- | $-6.2M | $-1.5M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $2.9M | $1.5M | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-23.2M | $-35.1M | $-41.7M | $-54.5M | $-67.1M | $-101.9M | $-83.7M | ||
| Pre-Tax Income | $-23.2M | $-35.1M | $-41.7M | $-54.6M | $-68.2M | $-100.3M | $-82.1M | ||
| NET INCOME | |||||||||
| Net Income | $-23.2M | $-35.1M | $-41.7M | $-54.6M | $-68.2M | $-101.9M | $-83.7M | ||
| Net Income (Continuing Operations) | $-23.2M | $-35.1M | $-41.7M | $-54.6M | $-68.2M | $-101.9M | $-83.7M | ||
| Net Income (Discontinued Operations) | $-23.2M | $-35.1M | $-41.7M | $-54.6M | $-68.2M | $-101.9M | $-83.7M | ||
| Net Income (Common Stockholders) | $-23.2M | $-35.1M | $-41.7M | $-54.6M | $-68.2M | $-101.9M | $-83.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-76.8M | ||
| TOTALS | |||||||||
| Total Expenses | $24.7M | $37.3M | $43.0M | $54.7M | $71.2M | $118.4M | $90.6M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $1.0M | $1.9M | $4.4M | $5.3M | $6.7M | $7.3M | $7.3M | ||
| Average Shares Outstanding (Diluted) | $1.0M | $1.9M | $4.4M | $5.3M | $6.7M | $7.3M | $7.3M | ||
| Shares Outstanding | $1.9M | $3.8M | $4.8M | $5.7M | $7.1M | $7.3M | $7.3M | ||
| Basic EPS | -- | $-18.4 | $-9.5 | $-10.4 | $-10.1 | $-14 | $-11.49 | ||
| Basic EPS (Continuing Operations) | -- | $-18.4 | $-9.5 | $-10.4 | $-10.1 | $-14 | $-11.49 | ||
| Diluted EPS | $-22.6 | $-18.4 | $-9.5 | $-10.4 | $-10.1 | $-14 | $-11.49 | ||
| Diluted EPS (Continuing Operations) | $-22.6 | -- | -- | -- | $-10.1 | $-14 | $-11.49 | ||
| OTHER METRICS | |||||||||
| Other Gand A | $6.6M | $10.0M | $12.0M | $15.7M | $20.2M | $26.5M | $23.4M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | $2.7M | $1.5M | ||
| Rent And Landing Fees | $-1.0M | $1.1M | $1.1M | $1.1M | $1.5M | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | $6.2M | $1.5M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KZR | $6.21 | -0.3% | 41.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kezar Life Sciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW